Dr. Edward M. Wolin
Claim this profileMount Sinai Hospital
Studies Neuroendocrine Tumors
Studies Pancreatic Neuroendocrine Tumors
6 reported clinical trials
14 drugs studied
Area of expertise
1Neuroendocrine Tumors
Stage IV
Stage III
SSTR positive
2Pancreatic Neuroendocrine Tumors
Stage IV
Stage III
Affiliated Hospitals
Mount Sinai Hospital
Mount Sinai School Of Medicine
Clinical Trials Edward M. Wolin is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
RYZ101
for Neuroendocrine Tumors
This trial tests RYZ101, a new drug, in patients with advanced GEP-NETs that haven't responded to previous treatments. The drug aims to target specific receptors on the tumor cells to stop their growth.
Recruiting2 awards Phase 312 criteria
More about Edward M. Wolin
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Edward M. Wolin has experience with
- Transarterial Chemoembolization
- Drug Eluting Beads Embolization
- Bland Embolization
- RYZ101
- 177Lu-Edotreotide
- Everolimus
Breakdown of trials Edward M. Wolin has run
Neuroendocrine Tumors
Pancreatic Neuroendocrine Tumors
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edward M. Wolin specialize in?
Edward M. Wolin focuses on Neuroendocrine Tumors and Pancreatic Neuroendocrine Tumors. In particular, much of their work with Neuroendocrine Tumors has involved Stage IV patients, or patients who are Stage III.
Is Edward M. Wolin currently recruiting for clinical trials?
Yes, Edward M. Wolin is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Edward M. Wolin has studied deeply?
Yes, Edward M. Wolin has studied treatments such as Transarterial chemoembolization, Drug Eluting Beads Embolization, Bland Embolization.
What is the best way to schedule an appointment with Edward M. Wolin?
Apply for one of the trials that Edward M. Wolin is conducting.
What is the office address of Edward M. Wolin?
The office of Edward M. Wolin is located at: Mount Sinai Hospital, New York, New York 10029 United States. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.